Table 4.
Period prevalence of selected STIs and other conditions among female sex workers attending GUM clinics in England in 2011 by migrant status
| UK-born FSW | Migrant FSW | Association with being a migrant female sex worker | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Period prevalence (%) | Diagnosed/tested* n/N | Period prevalence (%) | Diagnosed/tested* n/N | OR (unadjusted) | 95% CI | p Value | OR (adjusted†) | 95% CI | p Value | |
| Chlamydia‡ | 13.5 | 108/799 | 8.5 | 134/1581 | 0.59 | 0.46 to 0.79 | <0.001 | 0.61 | 0.38 to 0.97 | 0.04 |
| Gonorrhoea | 3.2 | 25/792 | 2.4 | 37/1576 | 0.74 | 0.44 to 1.23 | 0.25 | 1.00 | 0.38 to 2.70 | 0.99 |
| Syphilis | 0.1 | 1/722 | 0.1 | 2/1511 | 0.96 | 0.09 to 10.56 | 0.97 | 0.17 | 0.01 to 4.53 | 0.29 |
| HIV§ | 0.0 | 0/724 | 0.3 | 4/1511 | Omitted | Omitted | ||||
| Herpes | 3.0 | 26/858 | 2.1 | 35/1666 | 0.69 | 0.41 to 1.15 | 0.15 | 0.59 | 0.21 to 1.68 | 0.32 |
| Genital warts | 2.8 | 24/858 | 2.9 | 49/1666 | 1.05 | 0.64 to 1.73 | 0.84 | 1.92 | 0.72 to 5.10 | 0.19 |
| Hepatitis B | 0.1 | 1/858 | 0.7 | 12/1666 | 6.22 | 0.81 to 47.90 | 0.08 | Omitted | ||
| Hepatitis C | 0.5 | 4/858 | 0.1 | 2/1666 | 0.26 | 0.05 to 1.40 | 0.12 | Omitted | ||
| Trichomoniasis | 1.5 | 13/858 | 0.5 | 9/1666 | 0.35 | 0.15 to 0.83 | 0.02 | 0.17 | 0.05 to 0.59 | 0.01 |
| Scabies | 0.1 | 1/858 | 0.1 | 2/1666 | 1.03 | 0.09 to 11.38 | 0.98 | 0.42 | 0.02 to 11.98 | 0.62 |
| Molluscum contagiosum | 0.3 | 3/858 | 0.6 | 10/1666 | 1.72 | 0.47 to 6.27 | 0.41 | 0.77 | 0.12 to 5.37 | 0.80 |
| Bacterial vaginosis | 26.3 | 226/858 | 26.2 | 436/1666 | 0.99 | 0.82 to 1.20 | 0.93 | 0.81 | 0.58 to 1.15 | 0.24 |
| Candidosis | 13.3 | 114/858 | 18.9 | 315/1666 | 1.52 | 1.21 to 1.92 | <0.001 | 1.29 | 0.87 to 1.92 | 0.21 |
| Urinary tract infection | 4.8 | 41/858 | 9.3 | 155/1666 | 2.04 | 1.43 to 2.91 | <0.001 | 1.34 | 0.77 to 2.32 | 0.30 |
| Pelvic inflammatory disease | 3.8 | 33/858 | 14.3 | 238/1666 | 4.17 | 2.87 to 6.06 | <0.001 | 2.92 | 1.57 to 5.41 | 0.001 |
| Other conditions | 20.5 | 176/858 | 19.6 | 327/1666 | 0.95 | 0.77 to 1.16 | 0.60 | 0.83 | 0.57 to 1.19 | 0.30 |
| Abnormal cervical cell cytology | 25.5 | 13/51 | 35.3 | 95/269 | 3.93 | 2.19 to 7.06 | <0.001 | 1.19 | 0.52 to 2.73 | 0.69 |
Significant differences (p Value <0.05) highlighted in bold.
*For chlamydia, gonorrhoea, syphilis and HIV, N=women with a recorded test for the STI of interest; for abnormal cell cytology, N=women with a recorded smear test; and for all other STIs/conditions without a SHAPPT code for the relevant diagnostic test/investigation, N=all women.
†Adjusting for age, ethnicity, sexual orientation, location (inner London, outer London or outside London), deprivation of postcode of residence and chlamydia and/or gonorrhoea diagnosis.
‡Code suffixes to identify oral or rectal chlamydia infections were introduced to GUMCAD in 2011. However, as the use of these suffixes was not consistent across all clinics in 2011, the data presented here includes all chlamydia infections. In future, it will be possible to provide information on the site of infection.
§New HIV diagnoses in 2011.
FSW, female sex worker: GUM, genitourinary medicine; GUMCAD, Genitourinary Medicine Clinic Activity Dataset; STI, sexually transmitted infection.